forth. Thereby, gastrodin has been considered as a potential therapeutic agent for diverse diseases such as Tourette syndrome, 7 myocardial infarction, 8 alcoholic liver disease 6, 9 and acute lung injury. 10 However, the effects of gastrodin on COPD were not studied previously.
microRNAs (miRNAs) are a sort of small non-coding RNAs that are latterly discovered. They constitute approximately 1% of the total coding genes, and regulate more than 1/3 of protein-coding genes post-transcriptionally, which form the largest molecule regulation network. Because of this, miRNAs can participate in various physiological and pathological processes, including the onset and development of COPD. [11] [12] [13] For instance, in vivo and in vitro data demonstrated that miR-3202 could protect smokers from COPD. 14 Likewise, miR-181c was able to inhibit COPD which was induced by smoke. 15 In COPD, miR-103 was reported to be one of the aberrantly expressed miRNAs. 16 Besides that, miR-103 could participate in the regulation of inflammation in many aspects of human body, such as vasculature, 17 adipose tissue 18 and epicardial adipose tissue. 19 However, the functional impacts of miR-103 in COPD have not been studied before.
This study attempted to investigate the effect of gastrodin on a cell model of COPD, which was constructed by stimulating human lung fibroblast MRC-5 cells with lipopolysaccharides (LPSs). The expression change in miR-103 was also studied to decode the mechanism of which gastrodin exerted its function.
| MATERIAL S AND ME THODS

| Cell treatment
MRC-5 cells (ATCC) were cultured in EMEM (ATCC) which supplemented with 10% foetal bovine serum (Gibco). The cells were subcultured in 75-cm 2 flask and maintained at 37°C in humidified atmosphere with 5% CO 2 .
Cells were treated by 10 μg/mL LPS (Sigma-Aldrich) for 6 hours as described elsewhere. 20 Gastrodin (≥98% (HPLC), Sigma-Aldrich) was dissolved in DMSO (Sigma-Aldrich) to make a storage solution. Before use, the solution was diluted with EMEM to final concentrations of 50-300 μg/ mL. The cells were treated by gastrodin for 24 hours before LPS stimulation.
| Transfection
miR-103 mimic, miR-103 inhibitor (anti-miR-103) and the negative control (NC) were synthesized by GenePharma. Before transfection, cells were seeded into 6-well plates at the density of 5 × 10 5 / well. Cells were transfected with a final concentration of 5 nmol/L for miRNA mimic and 50 nmol/L for miRNA inhibitor through Lipofectamine 3000 (Invitrogen) following the producer's instructions. Transfection complexes were formed as follows: 100 pmoles miR-103-related sequences and 5 μL lipofectamine 3000 were blended, respectively, with 125 μL Opti-MEM (Invitrogen), keeping them in the room for 10 minutes under serum-free conditions. Cells were washed twice with PBS, and relative transfection complexes were put into every well. After 48 hours, the stably transfected cells were chosen for about 4 weeks through the culture medium with 0.5 mg/mL G418 (Sigma-Aldrich). G418-resistant cells were directly gathered latter.
| Cell viability
5000 cells in 96-well plates were treated as indicated. Cell viability was tested by adding 20 μL CCK-8 solution (Sangon Biotech).
4 hours later, the optical density (OD) at 450 nm was analysed by a microplate reader (Bio-Rad). 
| Apoptosis
| ELISA
Cells in 6-well plates were treated as indicated, and thereafter, the culture supernatant was collected. Concentrations of MCP-1, IL-6
and TNF-α were tested by ELISA Kits purchased from Abcam.
| qRT-PCR
Cells in 6-well plates were treated as indicated. RNA extraction was done by using TRIzol (Invitrogen), and the purity was verified by test- were utilized and U6 acted as reference controls.
| Western blot
The proteins in the pre-treated cells were isolated by using RIPA 
| Dual-luciferase assays
3′-UTR of lipoprotein receptor-related protein 1 (LRP1) was amplified through PCR and inserted into pmiR-Report vector (Promega), indicating LRP1 wild type (WT). GeneTailor Site-Directed Mutagenesis System (Invitrogen) was employed to get LRP1-mutated type (MUT), which was amplified via PCR and inserted into the same vector. The vectors were cotransfected with miR-103 mimic and its related control into cells. Dual-luciferase experiment system (Promega) was employed to get results.
| Statistics
Data presented as mean ± SD. Statistical difference was tested by SPSS 19.0 software (Chicago, IL) and presented as asterisk. Student's t test and ANOVA with Tukey post hoc analysis were conducted to compare the significant difference. P < .05 was considered as significant difference.
| RE SULTS
| LPS injured MRC-5 cells
MRC-5 cells were stimulated by 10 μg/mL LPS for 6 hours. As expected, cell viability was repressed (P < .05, Figure 1A ), whereas apoptosis rate was increased (P < .05, Figure 1B 
| Gastrodin prevents LPS-induced injury in MRC-5 cells
Various concentrations of gastrodin were utilized to treat MRC-5 cells for 24 hours. As result shown in Figure 2A gastrodin could significantly increase cell viability in LPS-induced cells in a dose-dependent way (P < .05, Figure 2B ). As 200 μg/mL gastrodin led to the highest viability in LPS-induced cells, it was selected as an optimum concentration used in the following. We found that pretreating MRC-5 cells with gastrodin attenuated LPS-induced apoptosis, as apoptosis rate was decreased (P < .05, Figure 2C ), Bcl-2 was up-regulated, Bax was down-regulated, and the cleavage of Caspase 3 and PARP was repressed (all P < .05, Figure 2D ,E). Not surprisingly, the expression and release induced by LPS were attenuated when pretreating with gastrodin (all P < .05, Figure 2F -H).
| Gastrodin inhibits p38/JNK and NF-κB pathways
The effects of gastrodin on p38/JNK and NF-κB pathways were investigated. As seen in Figure 3A 
| Gastrodin up-regulates miR-103 expression
Next, miR-103 expression was analysed following LPS and gastrodin treatment. Data in Figure 4 displayed that miR-103 was low expressed in LPS-induced cell (P < .05), whereas was highly expressed in gastrodin-treated cell even under LPS conditions (P < .05).
| Gastrodin prevents LPS-induced injury via miR-103
Finally, miR-103 expression in MRC-5 cells was silenced by transfection to decode the importance of miR-103 in gastrodin's protective Also, gastrodin did not repress LPS-induced release of pro-inflammatory cytokines when miR-103 was silenced (P < .05, Figure 5F -H).
| LRP1 was a target of miR-103
To investigate the target of miR-103, TargetScan (www.targe tscan. org) and microRNA database (www.micro rna.org) were employed to predict the binding site between LRP1 and miR-103 ( Figure 6A) .
Besides, the overexpression of miR-103 was achieved through transfection with miR-103 mimic (P < .001, Figure 6B ). And Figure 6C ,D revealed that the mRNA and protein levels of LRP1 were notably reduced by miR-103 overexpression (P < .05), while were notably increased by the inhibition of miR-103 (P < .01). Meanwhile, dual-luciferase assay revealed that luciferase activity of miR-103 mimic + LRP1-WT group was greatly reduced (P < .05), whereas that of miR-103 mimic + LRP1-MUT group was no changed ( Figure 6E ).
Thus, LRP1 was a target gene of miR-103 and was down-regulated by miR-103.
| D ISCUSS I ON
Considering COPD is a progressive disease, the damaged pulmonary function is hard to be reversed. Thus, preventing COPD has become a promising method for COPD management and a small fraction of researches have focused on the beneficial effects of traditional Chinese herbal medicine on this disease. 21 This study attempted to investigate the potential of gastrodin for COPD management. To this end, LPS was applied to treat MRC-5 cells to construct a cell model of COPD. Much was known that LPS is effective in inducing inflammatory response. 22, 23 This phenomenon was also appended in this 24 and neuroinflammation. 25 gastrodin may even attenuate LPS-induced acute lung injury. 10 Thus, it seems rationality that gastrodin could also protect MRC-5 cells against
LPS-induced inflammatory injury. Besides that, gastrodin is reported
to be an effective agent in resisting apoptosis made by various stimulations, such as hypoxic ischaemia, 26 ethanol, 9 high glucose 27 and LPS. 28 Consistently, gastrodin exhibited anti-apoptosis effect in our experimental system. Moreover, gastrodin prevented MRC-5 cell apoptosis possibly via a mitochondrial-dependent way, as the expression of main regulators Bcl-2 and Bax of this process was altered.
Much was known about the inductive impacts of LPS on various signalling pathways, such as JNK, NF-κB and p38MAPK. 29 These three pathways can be activated under cigarette stimulation, which can induce inflammatory response and drive the initiation of COPD. [30] [31] [32] Thus, inhibition of p38/JNK and NF-κB pathways has been considered as effective strategy for treating COPD. Herein, gastrodin was found to be effective in inhibiting LPS-induced p38/JNK and NF-κB pathways, which were in line with the findings reported elsewhere. 33, 34 The results indicated that gastrodin prevented LPS-induced injury in MRC-5 cells through these two signalling. Despite the underlying mechanisms of which herbal medicines exert their beneficial function are still unclear, scientists believed that miRNAs are main targets of them. 35 In regard to gastrodin, less was known about its regulation on miRNA expression. To date, only one report demonstrated that gastrodin could protect cardiomyocytes through up-regulating miR-21. 8 In the current study, we for the first time illustrated that gastrodin could elevate miR-103 expression. And the protective effects of gastrodin towards MRC-5 cells were partially flattened by miR-103 silence. Altogether, gastrodin prevented LPS-induced injury in MRC-5 cells possibly by up-regulating miR-103. Additionally, miR-103's expression was reported to be low in hypoxic pulmonary hypertension. 36 Besides, it was proved to promote LPS-induced inflammatory damage in HK-2 cells. 37 However, other studies found that miR-103 reduced apoptosis in LPS-caused PC12 cell injury to play protective roles. 38 This contradiction may due to the different cell lines or different irritations used in experimental system. In the future, it will be interesting to explore the functional mechanism of miR-103 in different cell situations.
Further, LRP1, a member of LDLR superfamily, 39 was reported to be a modulator of the inflammatory response in lung. 40 
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